Wholesale distribution of medicines is a key part of integrated supply chain management.
The guidelines put in place the appropriate tools to assist wholesalers and prevent counterfeit medicines from entering the legal supply chain. Adhering to these guidelines ensures we control the distribution chain and, as a result, maintain the quality and integrity of medicines.
The quality system should ensure that: ‘medicinal products are procured, held, supplied or exported in a way that is compliant with the requirements of GDP; management responsibilities are clearly specified; products are delivered to the right recipients within a satisfactory time period; records are made contemporaneously; deviations from established procedures are documented and investigated; appropriate corrective and preventive actions (commonly known as ‘CAPA’) are taken to correct deviations and prevent them in line with the principles of quality risk management.’
Guidelines of 5 November 2013 on Good Distribution Practice of medicinal products for human use (2013/C 68/01)
MSF Supply holds several licences granted by the Belgian Federal Agency for Medicines and Health Products (FAMHP):